Semler Scientific Inc.

36.55
-0.31 (-0.84%)
At close: Mar 31, 2025, 12:28 PM

Company Description

Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States.

The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups.

The company offers its products through salespersons and distributors.

Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.

Semler Scientific Inc.
Semler Scientific Inc. logo
Country United States
IPO Date Feb 21, 2014
Industry Medical - Devices
Sector Healthcare
Employees 79
CEO Dr. Douglas Murphy-Chutorian M.D.

Contact Details

Address:
2340-2348 Walsh Avenue
Santa Clara, California
United States
Website https://www.semlerscientific.com

Stock Details

Ticker Symbol SMLR
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001554859
CUSIP Number 81684M104
ISIN Number US81684M1045
Employer ID 26-1367393
SIC Code 3845

Key Executives

Name Position
Dr. Douglas Murphy-Chutorian M.D. Chief Executive Officer, President & Director
Jennifer Oliva Herrington Chief Operating Officer
Renae Cormier Chief Financial Officer, Principal Accounting Officer, Head of Corporation Communications & Bus. Strategy and Secretary
Shane Reid Chief Technology Officer
Cindy Guinasso Senior Vice President of Business Development
Dr. Herbert J. Semler Founder & Chairman Emeritus

Latest SEC Filings

Date Type Title
Feb 28, 2025 S-8 Filing
Feb 28, 2025 10-K Annual Report
Feb 18, 2025 8-K Current Report
Feb 14, 2025 SCHEDULE 13G Filing
Feb 13, 2025 SCHEDULE 13G/A [Amend] Filing
Feb 04, 2025 8-K Current Report
Feb 03, 2025 SCHEDULE 13G/A [Amend] Filing
Jan 28, 2025 8-K Current Report
Jan 24, 2025 8-K Current Report
Jan 23, 2025 8-K Current Report